Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. Currently, Gen9 offers multiple synthetic biology solutions for researchers who need high quality clonal, sequence-perfect DNA. Our award winning BioFab® process is remarkably flexible and very high throughput; allowing us to make the genes you need quickly at the highest quality available. Gen9 is Powering the Synthetic Biology Revolution.

Company Growth (employees)
Cambridge, US
Size (employees)
23 (est)-4%
Gen9 was founded in 2009 and is headquartered in Cambridge, US

Gen9 Office Locations

Gen9 has office in Cambridge
Cambridge, US

Gen9 Metrics

Gen9 Summary

Founding Date


Total Funding

$50.1 m

Latest funding size

$25 m

Time since last funding

over 2 years


We estimate that Gen9's latest funding round in July 2014 was $25 m. In total, Gen9 has raised $50.1 m
We estimate that Gen9's current employees are approximately 12% female and 88% male.

Gen9 Online Presence

Gen9 Company Life

You may also be interested in